NCT04784104

Brief Summary

Ultrasound-guided brachial plexus blocks are used successfully for upper extremity surgeries. In this randomized prospective single-blind study, ASA I-II patients aged 18-65 years undergoing hand, wrist, and forearm surgery will be randomly divided into two groups. First group will receive ultrasound-guided coronal oblique supraclavicular block using a 22G, 50 mm stimulator needle, and the second group, ultrasound-guided lateral sagittal infraclavicular block using a 22G 100 mm stimulator needle. We will prepare, 30 ml of 1:1 0.5% bupivacaine and 2% prilocaine with 5 mcg adrenaline per milliliter as local anesthetic mixture. Block application time, block success, sensory and motor block levels, and postoperative analgesia time will be recorded and compared between the groups. Accordingly, the success rate of the two methods will be evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Mar 2021

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

March 5, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

March 5, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2021

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

March 5, 2021

Status Verified

March 1, 2021

Enrollment Period

5 months

First QC Date

March 2, 2021

Last Update Submit

March 2, 2021

Conditions

Keywords

Brachial plexus blockNerve block

Outcome Measures

Primary Outcomes (9)

  • Block Formation Time

    Block formation time will be defined as the time required to initiate anesthesia and analgesia in all 5 distal nerves.

    30th minute pre-operatively

  • Block Application Time

    Block application time will be defined as the time from the moment the needle passes the skin until the local anesthetic is given and withdrawn.

    During Block Application

  • Block success

    Block success; at the 30th minute of local anesthesic application, the pinprick test will define the presence of insensibility or only a sense of touch in the musculocutaneous, radial, ulnar, median, cutaneous antebrachii nerves. If any of these nerves are not blocked, it will be considered a failed block.

    At the 30th minute of LA application

  • Sensory Block Level 5th minute

    Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).

    5th minute

  • Sensory Block Level 10th minute

    Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).

    10th minute

  • Sensory Block Level 15th minute

    Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).

    15th minute

  • Sensory Block Level 20th minute

    Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).

    20th minute

  • Sensory Block Level 25th minute

    Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).

    25th minute

  • Sensory Block Level 30th minute

    Sensory block level; axillary, median, radial, ulnar, musculocutaneous, cutaneous brachia, and cutaneous antebrachii medialis nerve level will be evaluated with the pinprick test and its level will be recorded. (0 = painful, no block; 1 = partial block-analgesia, only tactile sensation; 2 = complete block, no pain).

    30th minute

Secondary Outcomes (13)

  • The Motor Block Level 10th minute

    10th minute

  • Postoperative Analgesia Time

    24 hours post-operatively

  • Pain Score Follow-up 2nd Hour

    2nd hour

  • Block Return Time

    24 hours postoperatively

  • Patient and Surgeon Satisfaction

    Immediately after the surgery

  • +8 more secondary outcomes

Study Arms (2)

Supraclaviculer block

EXPERIMENTAL

The coronal oblique supraclavicular block will be applied to the first group with ultrasound guidance using a 22G 50 mm stimulator needle. 30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine, 2 ml saline with 5 mcg adrenaline per ml.) Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture.

Drug: Bupivacaine HCl 0.5% Injectable SolutionDrug: Prilocaine HCl 2% Injectable solutionDrug: Adrenaline amp. 0.5 mgProcedure: Ultrasound guided supraclavicular block with coronal oblique method

Infraclaviculer block

EXPERIMENTAL

The lateral sagittal infraclavicular block will be applied to the second group with ultrasound guidance using a 22G 100 mm stimulator needle. 30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine, 2 ml saline with 5 mcg adrenaline per ml.). Intermittent negative aspiration will be performed during all procedures to detect possible vascular puncture.

Drug: Bupivacaine HCl 0.5% Injectable SolutionDrug: Prilocaine HCl 2% Injectable solutionDrug: Adrenaline amp. 0.5 mgProcedure: Ultrasound guided lateral sagittal infraclavicular block

Interventions

30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)

Also known as: Bupivacaine 0.5%
Infraclaviculer blockSupraclaviculer block

30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)

Also known as: Priloc %2
Infraclaviculer blockSupraclaviculer block

30 ml of bupivacaine (Bupivacaine HCl %0.5) and prilocaine (Priloc HCl %2) 1:1 mixture will be prepared in a way that there will be 5 mcg adrenaline per ml. (14 ml. bupivacaine, 14 ml. prilocaine and 2 ml saline with 5 mcg adrenaline per ml.)

Also known as: Adrenalin codex 0.5 mg 1 ml injectable solution
Infraclaviculer blockSupraclaviculer block

The blocks will be performed by an experienced anesthesiologist with a USG guidence.

Supraclaviculer block

The blocks will be performed by an experienced anesthesiologist with USG guidence.

Infraclaviculer block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • ASA I-II
  • Patients scheduled for hand, wrist, and forearm surgery

You may not qualify if:

  • Uncoordinated patients
  • Having a disease that prevents sensory block evaluation,
  • Have coagulopathy,
  • Known allergies to drugs to be used,
  • Those with anatomical disorders at the application points
  • Pregnant patients,
  • Patients under 18 years of age,
  • Patients with known local anesthetic allergy,
  • Patients diagnosed with sepsis and bacteriemia,
  • Skin infection at the injection site.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Izmir Bozyaka Training and Research Hospital

Izmir, Karabağlar, 35170, Turkey (Türkiye)

Location

Related Publications (3)

  • Gurkan Y, Hosten T, Tekin M, Acar S, Solak M, Toker K. [Comparison of ultrasound-guided supraclavicular and infraclavicular approaches for brachial plexus blockade]. Agri. 2012;24(4):159-64. doi: 10.5505/agri.2012.38247. Turkish.

    PMID: 23364778BACKGROUND
  • Grape S, Pawa A, Weber E, Albrecht E. Retroclavicular vs supraclavicular brachial plexus block for distal upper limb surgery: a randomised, controlled, single-blinded trial. Br J Anaesth. 2019 Apr;122(4):518-524. doi: 10.1016/j.bja.2018.12.022. Epub 2019 Jan 31.

    PMID: 30857608BACKGROUND
  • Arcand G, Williams SR, Chouinard P, Boudreault D, Harris P, Ruel M, Girard F. Ultrasound-guided infraclavicular versus supraclavicular block. Anesth Analg. 2005 Sep;101(3):886-890. doi: 10.1213/01.ANE.0000159168.69934.CC.

    PMID: 16116009BACKGROUND

MeSH Terms

Conditions

Pain, PostoperativeAgnosia

Interventions

BupivacainePrilocaine

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Mehmet E Şen, MD

    Izmir Bozyaka Training and Research Hospital

    STUDY CHAIR
  • Zeki T Tekgül, Assoc Prof

    Izmir Bozyaka Training and Research Hospital

    STUDY CHAIR
  • Taşkın Altay, Assoc Prof

    Izmir Bozyaka Training and Research Hospital

    STUDY CHAIR

Central Study Contacts

Mehmet E Şen, MD

CONTACT

Zeki T Tekgül, Assoc Prof

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study covers 2 groups. Supraclavicular block will be applied to the first group and infraclavicular block will be applied to the second group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Anesthesiology Resident

Study Record Dates

First Submitted

March 2, 2021

First Posted

March 5, 2021

Study Start

March 5, 2021

Primary Completion

August 15, 2021

Study Completion

September 1, 2021

Last Updated

March 5, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations